科研之友
微信
新浪微博
Facebook
分享链接
摘要
Early-breast cancer treatment is based on a multimodality approach with the common use of clinical and histological prognostic factors to determine locoregional and systemic treatments. The entire scientific community is strongly involved in the management: of this disease: radiologists for screening and early diagnosis, gynaecologists, surgery oncologists and radiation oncologists for locoregional treatments, pathologists and biologists for personalized characterization and medical oncologists for systemic therapies. Recently, new biological tools have established different prognostic subsets of breast cancers and developed predictive markers to miscellaneous treatments. The aim of this article is to detail the contribution of biological tools in the locoregional management of early breast cancer.
- 出版日期2010-1
